A downtrend has been apparent in Outset Medical, Inc. (OM) lately. While the stock has lost 9.9% over the past week, it could ...

Outset Medical (Nasdaq: OM) shares got a boost today on fourth-quarter results that topped the consensus forecast on Wall ...

Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of ...

Outset Medical is prominently recognized for its innovative Tablo Hemodialysis System, which revolutionized the dialysis ...

Outset Medical (Nasdaq: OM) announced today that the FDA says it addressed all issues cited in a 2023 warning letter.

RBC Capital analyst Shagun Singh Chadha maintained a Hold rating on Outset Medical (OM – Research Report) yesterday and set a price target of ...

SAN JOSE, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology ...

Outset Medical delivered sequential revenue growth and continued gross margin expansion in Q4 2024, supported by recurring revenue strength and cost management. With a recapitalized balance sheet ...

Outset Medical Inc (NASDAQ:OM) is set to release its Q4 2024 earnings on Feb 19, 2025. The consensus estimate for Q4 2024 ...

Revenue surpassed consensus expectations at $29.5 million. Outset Medical's non-GAAP gross margin improved significantly, rising to 37.7%. The company saw an 28% reduction in operating expenses ...

Outset Medical (NASDAQ:OM), the innovator behind the Tablo Hemodialysis System, reported fourth-quarter earnings on Wednesday, Feb. 19, that topped analysts' consensus expectations on top and ...